2018 Oral Mucositis Drug Development- Pipeline Analysis Report

  • ID: 4527574
  • Report
  • 70 pages
  • VPA Research
1 of 4
With an estimated $2 billion market value, the Oral Mucositis disease pipeline presents strong opportunities for development of treatment options. Absence of preventive or curative treatment for the Oral Mucositis is encouraging investigators in major companies to focus on pipeline. Further, an increasing trend towards grant announcements is being observed in the segment.
The disease occurs primarily as a result of damage to epithelium by chemoradiation.

Over 30 companies and universities are focusing on developing treatment options for Oral Mucositis.

To assist investigators and funding and regulatory organizations, the publisher has come up with a comprehensive report on Oral Mucositis pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Oral Mucositis pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Oral Mucositis pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
Note: Product cover images may vary from those shown
2 of 4
1.1 List of Figures
1.2 List of Tables

2 Oral Mucositis Pipeline Analysis
2.1 Disease and Pipeline Overview
2.2 Oral Mucositis Pipeline Snapshot
2.3 Oral Mucositis Pipeline by Phase
2.4 Oral Mucositis Pipeline by Company
2.5 Oral Mucositis Pipeline by Mechanism of Action

3 Oral Mucositis- Company Wise Pipeline Analysis
  • ActoGeniX
  • BIOCND
  • Clevexel Pharma
  • Colby Pharmaceutical Company
  • Daewoong Pharmaceutical
  • Enzychem Lifesciences Corporation
  • Galera Therapeutics
  • Genekey Biotech Chengdu Co Ltd
  • GlycoMira Therapeutics
  • Humanetics Corporation
  • Hyloris Pharmaceuticals
  • INC Research Australia Pty Ltd
  • Innovation Pharmaceuticals
  • Intrexon
  • Izun Pharmaceuticals Corporation
  • Monopar Therapeutics
  • Mundipharma International Ltd
  • Novartis Pharmaceuticals
  • Onxeo S.A.
  • Oragenics
  • PolyMedix
  • Santalis Pharmaceuticals
  • SciClone Pharmaceuticals, Inc.
  • Servier Canada Inc
  • Soligenix In
  • Spectrum Pharmaceuticals
  • Spherium Biomed S.L.
  • SRI International
  • Sunny Pharmtech
  • Wellstat Therapeutics Corporation
4 Oral Mucositis R&D Pipeline Snapshots
  • Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/ License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details

5 Recent Developments in Oral Mucositis Pipeline

6 Appendix
6.1 About the Publisher
6.2 Sources and Research Methodology

1.1 List of Figures
Figure 1: Oral Mucositis Pipeline by Phase, H1- 2018
Figure 2: Oral Mucositis Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Oral Mucositis Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018

1.2 List of Tables
Table 1: Oral Mucositis Pipeline by Phase, H1- 2018
Table 2: Oral Mucositis Pipeline by Companies, H1- 2018
Table 3: Oral Mucositis Pipeline by Mechanism of Action, H1- 2018
Table 4: ActoGeniX Oral Mucositis Pipeline, May 2018
Table 5: BIOCND Oral Mucositis Pipeline, May 2018
Table 6: Clevexel Pharma Oral Mucositis Pipeline, May 2018
Table 7: Colby Pharmaceutical Company Oral Mucositis Pipeline, May 2018
Table 8: Daewoong Pharmaceutical Oral Mucositis Pipeline, May 2018
Table 9: Enzychem Lifesciences Corporation Oral Mucositis Pipeline, May 2018
Table 10: Galera Therapeutics Oral Mucositis Pipeline, May 2018
Table 11: Genekey Biotech Chengdu Co Ltd Oral Mucositis Pipeline, May 2018
Table 12: GlycoMira Therapeutics Oral Mucositis Pipeline, May 2018
Table 13: Humanetics Corporation Oral Mucositis Pipeline, May 2018
Table 14: Hyloris Pharmaceuticals Oral Mucositis Pipeline, May 2018
Table 15: INC Research Australia Pty Ltd Oral Mucositis Pipeline, May 2018
Table 16: Innovation Pharmaceuticals Oral Mucositis Pipeline, May 2018
Table 17: Intrexon Oral Mucositis Pipeline, May 2018
Table 18: Izun Pharmaceuticals Corporation Oral Mucositis Pipeline, May 2018
Table 19: Monopar Therapeutics Oral Mucositis Pipeline, May 2018
Table 20: Mundipharma International Ltd Oral Mucositis Pipeline, May 2018
Table 21: Novartis Pharmaceuticals Oral Mucositis Pipeline, May 2018
Table 22: Onxeo S.A. Oral Mucositis Pipeline, May 2018
Table 23: Oragenics Oral Mucositis Pipeline, May 2018
Table 24: PolyMedix Oral Mucositis Pipeline, May 2018
Table 25: Santalis Pharmaceuticals Oral Mucositis Pipeline, May 2018
Table 26: SciClone Pharmaceuticals, Inc. Oral Mucositis Pipeline, May 2018
Table 27: Servier Canada Inc Oral Mucositis Pipeline, May 2018
Table 28: Soligenix In Oral Mucositis Pipeline, May 2018
Table 29: Spectrum Pharmaceuticals Oral Mucositis Pipeline, May 2018
Table 30: Spherium Biomed S.L. Oral Mucositis Pipeline, May 2018
Table 31: SRI International Oral Mucositis Pipeline, May 2018
Table 32: Sunny Pharmtech Oral Mucositis Pipeline, May 2018
Table 33: Wellstat Therapeutics Corporation Oral Mucositis Pipeline, May 2018
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Anthera Pharmaceuticals Inc
  • AstraZeneca Plc
  • Cilian AG
  • Laboratoires Mayoly Spindler SAS
  • Nordmark Arzneimittel GmbH & Co KG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll